Skip to Main Content
Christmas Tree
NEW YEAR SALE

50% off your first year of Quiver Premium

...

Use Promo Code:

NYE26BANNER
Christmas Tree Snow
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Insider Sale: Chief Executive Officer of $ARWR Sells 982 Shares

Automated

Christopher Richard Anzalone, the Chief Executive Officer of $ARWR, sold 982 shares of the company on 12-17-2025 for an estimated $64,350. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.0% of their shares of this class of stock. Following this trade, they now own 3,833,938 shares of this class of $ARWR stock.

$ARWR Insider Trading Activity

ARWR Insider Trades

$ARWR insiders have traded $ARWR stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales.

Here’s a breakdown of recent trading of $ARWR stock by insiders over the last 6 months:

  • CHRISTOPHER RICHARD ANZALONE (Chief Executive Officer) has made 0 purchases and 4 sales selling 85,000 shares for an estimated $5,443,462.
  • JAMES C HAMILTON (Chief Medical Officer) has made 0 purchases and 5 sales selling 60,000 shares for an estimated $1,725,000.
  • MICHAEL S PERRY sold 16,250 shares for an estimated $991,737
  • MAURO FERRARI sold 8,750 shares for an estimated $493,412

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$ARWR Hedge Fund Activity

We have seen 171 institutional investors add shares of $ARWR stock to their portfolio, and 152 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$ARWR Analyst Ratings

Wall Street analysts have issued reports on $ARWR in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Piper Sandler issued a "Overweight" rating on 12/17/2025
  • Chardan Capital issued a "Buy" rating on 12/01/2025
  • B of A Securities issued a "Buy" rating on 12/01/2025
  • RBC Capital issued a "Outperform" rating on 11/19/2025
  • HC Wainwright & Co. issued a "Buy" rating on 10/08/2025

To track analyst ratings and price targets for $ARWR, check out Quiver Quantitative's $ARWR forecast page.

$ARWR Price Targets

Multiple analysts have issued price targets for $ARWR recently. We have seen 7 analysts offer price targets for $ARWR in the last 6 months, with a median target of $80.0.

Here are some recent targets:

  • Edward Tenthoff from Piper Sandler set a target price of $100.0 on 12/17/2025
  • Luca Issi from RBC Capital set a target price of $80.0 on 12/11/2025
  • Jason Gerberry from B of A Securities set a target price of $81.0 on 12/09/2025
  • Patrick R. Trucchio from HC Wainwright & Co. set a target price of $85.0 on 12/02/2025
  • Keay Nakae from Chardan Capital set a target price of $60.0 on 12/01/2025
  • Michael Ulz from Morgan Stanley set a target price of $48.0 on 11/26/2025
  • Andrea Tan from Goldman Sachs set a target price of $48.0 on 11/20/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles